HK1252275A1 - 羥烷基噻二唑衍生物 - Google Patents

羥烷基噻二唑衍生物

Info

Publication number
HK1252275A1
HK1252275A1 HK18111652.6A HK18111652A HK1252275A1 HK 1252275 A1 HK1252275 A1 HK 1252275A1 HK 18111652 A HK18111652 A HK 18111652A HK 1252275 A1 HK1252275 A1 HK 1252275A1
Authority
HK
Hong Kong
Prior art keywords
thiadiazole derivatives
hydroxyalkyl
hydroxyalkyl thiadiazole
derivatives
thiadiazole
Prior art date
Application number
HK18111652.6A
Other languages
English (en)
Inventor
Manoj Kumar Khera
Tarun Mathur
Jitendra A Sattigeri
Nobuhisa Masuda
Tsuyoshi Soneda
Yoshiko Kagoshima
Toshiyuki Konosu
Tetsuya Suzuki
Makoto Yamaoka
Ryo Itooka
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of HK1252275A1 publication Critical patent/HK1252275A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK18111652.6A 2015-09-30 2018-09-11 羥烷基噻二唑衍生物 HK1252275A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3119DE2015 2015-09-30

Publications (1)

Publication Number Publication Date
HK1252275A1 true HK1252275A1 (zh) 2019-05-24

Family

ID=57218949

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18111652.6A HK1252275A1 (zh) 2015-09-30 2018-09-11 羥烷基噻二唑衍生物

Country Status (19)

Country Link
US (1) US10399968B2 (zh)
EP (1) EP3356361B1 (zh)
JP (1) JP6824256B2 (zh)
KR (1) KR20180054650A (zh)
CN (1) CN108137574B (zh)
AU (1) AU2016330271B2 (zh)
BR (1) BR112018006276A2 (zh)
CA (1) CA2999982C (zh)
CO (1) CO2018003548A2 (zh)
ES (1) ES2817749T3 (zh)
HK (1) HK1252275A1 (zh)
IL (1) IL258411B (zh)
MX (1) MX2018003562A (zh)
MY (1) MY184406A (zh)
PH (1) PH12018500697A1 (zh)
RU (1) RU2737892C1 (zh)
TW (1) TW201731844A (zh)
WO (1) WO2017056012A1 (zh)
ZA (1) ZA201801718B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2817749T3 (es) * 2015-09-30 2021-04-08 Daiichi Sankyo Co Ltd Derivados de hidroxialquil tiadiazol
US10752647B2 (en) 2017-03-14 2020-08-25 Daiichi Sankyo Company, Limited N-phosphonoxymethyl prodrugs of hydroxyalkyl thiadiazole derivatives
US20210323957A1 (en) 2018-09-03 2021-10-21 Univerza V Ljubljani New class of dna gyrase and/or topoisomerase iv inhibitors with activity against gram-positive and gram-negative bacteria
EP4263503A1 (en) 2020-12-17 2023-10-25 Univerza V Ljubljani New n-phenylpyrrolamide inhibitors of dna gyrase and topoisomerase iv with antibacterial activity
CN115466246B (zh) * 2021-06-11 2024-02-06 中国医学科学院药物研究所 吡咯酰哌啶胺类化合物及其用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200526626A (en) 2003-09-13 2005-08-16 Astrazeneca Ab Chemical compounds
JP2008530193A (ja) 2005-02-18 2008-08-07 アストラゼネカ アクチボラグ 化合物
CN101163697A (zh) 2005-02-18 2008-04-16 阿斯利康(瑞典)有限公司 作为dna促旋酶和拓扑异构酶抑制剂的吡咯衍生物
AU2006215399B2 (en) 2005-02-18 2010-12-09 Astrazeneca Ab Antibacterial piperidine derivatives
EP1861393A2 (en) 2005-03-04 2007-12-05 AstraZeneca AB Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
WO2006092608A1 (en) 2005-03-04 2006-09-08 Astrazeneca Ab Tricyclic derivatives of azetidine and pyrrole with antibacterial activity
WO2007071965A2 (en) 2005-12-23 2007-06-28 Astrazeneca Ab Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines
TW200819437A (en) * 2006-08-17 2008-05-01 Astrazeneca Ab Chemical compounds
WO2008020227A2 (en) 2006-08-17 2008-02-21 Astrazeneca Ab Antibacterial pyrrolecarboxamides
WO2008020229A2 (en) 2006-08-17 2008-02-21 Astrazeneca Ab Antibacterial pyrrolecarboxamides
TW200906412A (en) 2007-06-12 2009-02-16 Astrazeneca Ab Piperidine compounds and uses thereof
TWI498115B (zh) 2007-12-27 2015-09-01 Daiichi Sankyo Co Ltd 咪唑羰基化合物
EP2326640A1 (en) 2008-07-30 2011-06-01 Ranbaxy Laboratories Limited Pyrrole carboxylic acid derivatives as antibacterial agents
TW201026694A (en) 2008-12-12 2010-07-16 Astrazeneca Ab Compound 468
US8071605B2 (en) 2008-12-12 2011-12-06 Astrazeneca Ab Piperidine compounds for use in the treatment of bacterial infections
JP2011026305A (ja) 2009-06-24 2011-02-10 Daiichi Sankyo Co Ltd イミダゾールカルボニル化合物を含有する医薬組成物
EP2906216B1 (en) 2012-10-10 2020-06-24 Kumar, Ajay Inhibitors of dna gyrase for the treatment of bacterial infections
ES2817749T3 (es) * 2015-09-30 2021-04-08 Daiichi Sankyo Co Ltd Derivados de hidroxialquil tiadiazol

Also Published As

Publication number Publication date
AU2016330271B2 (en) 2020-04-30
JP2018529696A (ja) 2018-10-11
RU2737892C1 (ru) 2020-12-04
AU2016330271A1 (en) 2018-04-12
IL258411A (en) 2018-05-31
KR20180054650A (ko) 2018-05-24
CN108137574B (zh) 2021-12-28
IL258411B (en) 2021-08-31
BR112018006276A2 (pt) 2018-10-16
PH12018500697A1 (en) 2018-10-01
ZA201801718B (en) 2019-01-30
CO2018003548A2 (es) 2018-07-19
MX2018003562A (es) 2018-06-19
EP3356361B1 (en) 2020-07-08
US20180327399A1 (en) 2018-11-15
US10399968B2 (en) 2019-09-03
EP3356361A1 (en) 2018-08-08
JP6824256B2 (ja) 2021-02-03
MY184406A (en) 2021-04-01
CN108137574A (zh) 2018-06-08
CA2999982C (en) 2020-07-28
TW201731844A (zh) 2017-09-16
CA2999982A1 (en) 2017-04-06
ES2817749T3 (es) 2021-04-08
WO2017056012A1 (en) 2017-04-06

Similar Documents

Publication Publication Date Title
HK1255045A1 (zh) 取代的氧代吡啶衍生物
SG11201706729SA (en) Derivatives of sobetirome
IL253381A0 (en) History of h9-pyrrolo-dipyridine
IL271607A (en) New azaquinoline histories
IL263050B (en) History of Subtirum
HK1245258A1 (zh) 新的二氟酮酰胺衍生物
IL271290A (en) Dihydro-pyrrolo-pyridine derivatives
HK1252275A1 (zh) 羥烷基噻二唑衍生物
HUE050450T2 (hu) Fluoralkil-fluorén-származékok
LT3652176T (lt) Pakeisti ksantino dariniai
IL248773A0 (en) History of naphthyridinedione
IL248629A0 (en) Substances containing diheteroaryl conjugated to cycloalkyl and their uses
IL251005B (en) Pyrido-oxazinone derivatives
HK1254202A1 (zh) 三唑衍生物
PL3119744T3 (pl) Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu
GB201416351D0 (en) Heterocyclic derivatives
PT3319956T (pt) Derivados de oxopiridina substituída